{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:59:30Z","timestamp":1791489570260,"version":"4.3.4"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1663,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1469-1809.2010.00638.x","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T06:56:21Z","timestamp":1298012181000},"page":"236-246","source":"Crossref","is-referenced-by-count":54,"title":["Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations"],"prefix":"10.1111","volume":"75","author":[{"given":"Laura J.","family":"Horsfall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zeitlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayele","family":"Tarekegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endashaw","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bradman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas M.","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,11]]},"reference":[{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?","volume":"95","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/jhep.2000.18193","article-title":"Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects","volume":"32","author":"Borlak","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB5|cit5","first-page":"613","article-title":"La maladie de Gilbert chez le Noir Africain: A propos de 4 observations au Centre Hospitalier National de Ouagadougou","volume":"45","author":"Bougouma","year":"1999","journal-title":"Medecine d\u2019Afrique Noire"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e318142be0d","article-title":"Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome","volume":"335","author":"Buyukasik","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21264","article-title":"UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia","volume":"63","author":"Carpenter","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB8|cit8","first-page":"188","article-title":"Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia","volume":"90","author":"Chaar","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1158\/1078-0432.CCR-06-2290","article-title":"UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan","volume":"13","author":"Cote","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.tpj.6500221","article-title":"A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia","volume":"4","author":"Danoff","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/117693430500100003","article-title":"Arlequin (version 3.0): An integrated software package for population genetics data analysis","volume":"1","author":"Excoffier","year":"2005","journal-title":"Evol Bioinform Online"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB12|cit12","first-page":"588","article-title":"The prevalence of isolated unconjugated hyperbilirubinaemia (Gilbert's syndrome) in subjects attending a health screening programme in Singapore","volume":"33","author":"Gwee","year":"1992","journal-title":"Singapore Med J"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2003.28","article-title":"UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia","volume":"141","author":"Heeney","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.106.014183","article-title":"UDP-glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women","volume":"35","author":"Hong","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/jnci\/djm115","article-title":"UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters","volume":"99","author":"Hoskins","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/FPC.0b013e328012d0da","article-title":"Molecular pathogenesis of Gilbert's syndrome: Decreased TATA-binding protein binding affinity of UGT1A1 gene promoter","volume":"17","author":"Hsieh","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00008571-200212000-00006","article-title":"Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups","volume":"12","author":"Innocenti","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01213011-200505000-00004","article-title":"Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes","volume":"15","author":"Innocenti","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.2004.07.173","article-title":"Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan","volume":"22","author":"Innocenti","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1203\/PDR.0b013e31815b8e7e","article-title":"(TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates","volume":"63","author":"Kaplan","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0006-2952(03)00074-1","article-title":"Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians","volume":"65","author":"Kohle","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI101304","article-title":"Latent liver disease in persons recovered from catarrhal jaundice and in otherwise normal medical students as revealed by the bilirubin excretion test","volume":"21","author":"Kornberg","year":"1942","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.freeradbiomed.2007.10.057","article-title":"Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species","volume":"44","author":"Kumar","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008571-199906000-00009","article-title":"UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations","volume":"9","author":"Lampe","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.21361","article-title":"Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype","volume":"44","author":"Lankisch","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2008.12.030","article-title":"Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy-an extended haplotype of genetic variants increases risk in indinavir treatment","volume":"50","author":"Lankisch","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1055-9965.EPI-07-2517","article-title":"Gilbert's Syndrome and irinotecan toxicity: Combination with UDP-glucuronosyltransferase 1A7 variants increases risk","volume":"17","author":"Lankisch","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.106.633206","article-title":"Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study","volume":"114","author":"Lin","year":"2006","journal-title":"Circulation"},{"issue":"Pt 2","key":"10.1111\/j.1469-1809.2010.00638.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3200681","article-title":"Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro","volume":"320","author":"McPhee","year":"1996","journal-title":"Biochem J"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/humu.20946","article-title":"Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population","volume":"30","author":"Menard","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(00)75817-X","article-title":"Defensive role of bilirubinemia in pneumococcal infection","volume":"229","author":"Najib","year":"1937","journal-title":"The Lancet"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB32|cit32","unstructured":"New Drug Application 20-571 - Final label - UGT1A1 Camptosar-\u00ae(irinotecan HCl) http:\/\/www.fda.gov\/MedWatch\/safety\/2005\/Jun_PI\/Camptosar_PI.pdf"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: A meta-analysis of published studies","volume":"228","author":"Novotny","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00228-006-0166-3","article-title":"UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females","volume":"62","author":"Odeberg","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmg.12.2.152","article-title":"Population studies on Gilbert's syndrome","volume":"12","author":"Owens","year":"1975","journal-title":"J Med Genet"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00043426-200110000-00011","article-title":"Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia","volume":"23","author":"Passon","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1079-9796(03)00071-8","article-title":"The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications","volume":"31","author":"Premawardhena","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328011d7c1","article-title":"Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia","volume":"21","author":"Rodriguez-Novoa","year":"2007","journal-title":"Aids"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB39|cit39","first-page":"194","article-title":"TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome","volume":"30","author":"Sampietro","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1013794407325","article-title":"Serum bilirubin and 10-year mortality risk in a Belgian population","volume":"12","author":"Temme","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/FPC.0b013e3283097311","article-title":"The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa","volume":"18","author":"Veeramah","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1124\/dmd.105.005447","article-title":"In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1469-1809.2010.00638.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.1840400412","article-title":"Serum bilirubin levels in the U.S. population: Gender effect and inverse correlation with colorectal cancer","volume":"40","author":"Zucker","year":"2004","journal-title":"Hepatology"}],"container-title":["Annals of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-1809.2010.00638.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1469-1809.2010.00638.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T23:05:41Z","timestamp":1637276741000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-1809.2010.00638.x"}},"subtitle":["UGT1A in African populations"],"short-title":[],"issued":{"date-parts":[[2011,2,11]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1469-1809.2010.00638.x","relation":{},"ISSN":["0003-4800"],"issn-type":[{"value":"0003-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,11]]}}}